Table 2.
Comparison of Serum S100B, MMP-9, D-Dimer Concentrations on Admission and at 24 hours in Patients who had achieved Poor versus Improved Clinical Satus at 72 hours after Admission
| Biomarkers | Poor Outcome (Death or GCS ≤ 8) |
Good Outcome (GCS > 8) |
p-value | ||
|---|---|---|---|---|---|
| N | Median | N | Median | ||
| Admission | |||||
| S100B (ng/ml) | 30 | 1.88 | 14 | 0.28 | 0.007 |
| MMP-9 (ng/ml) | 30 | 438.26 | 14 | 183.82 | 0.115 |
| D-Dimer (ng/dl) | 30 | 9586.82 | 14 | 7769.50 | 0.425 |
| 24 hours | |||||
| S100B (ng/ml) | 28 | 0.60 | 14 | 0.16 | 0.003 |
| MMP-9 (ng/ml) | 28 | 25.00 | 14 | 22.61 | 0.535 |
| D-Dimer (ng/dl) | 28 | 7753.11 | 14 | 2590.07 | 0.000 |